The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Fragment-based lead discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Molecular properties that influence the oral bioavailability of drug candidates
Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020017n · Cited by 8,420
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
Ligand efficiency: a useful metric for lead selection
Hopkins, A. L., Groom, C. R., & Alex, A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03069-7 · Cited by 1,846
Green, N. M. (1975) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60411-8 · Cited by 1,458
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R., Murray, C., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,354
Self-citationOn the attribution and additivity of binding energies
Jencks, W. P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.7.4046 · Cited by 912
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
The Design of Leadlike Combinatorial Libraries
Teague, S. J., Davis, A. M., Leeson, P. D., & Oprea, T. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991216)38:24<3743::aid-anie3743>3.0.co;2-u · Cited by 870
Is There a Difference between Leads and Drugs? A Historical Perspective
Oprea, T. I., Davis, A. M., Teague, S. J., & Leeson, P. D. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010366a · Cited by 769
Implications of protein flexibility for drug discovery
Teague, S. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1129 · Cited by 755
Lewis, W. G., Green, L. G., Grynszpan, F., Radić, Z., Carlier, P. R., Taylor, P., Finn, M. G., & Sharpless, K. B. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020315)41:6<1053::aid-anie1053>3.0.co;2-4 · Cited by 744
Erlanson, D. A., McDowell, R. S., & O'Brien, T. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040031v · Cited by 642
A Comparison of Physiochemical Property Profiles of Development and Marketed Oral Drugs
Wenlock, M. C., Austin, R. P., Barton, P., Davis, A. M., & Leeson, P. D. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021053p · Cited by 546
High-throughput crystallography for lead discovery in drug design
Blundell, T. L., Jhoti, H., & Abell, C. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd706 · Cited by 530
Drug discovery by dynamic combinatorial libraries
Ramström, O., & Lehn, J.-M. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd704 · Cited by 511
Site-directed ligand discovery
Erlanson, D. A., Braisted, A. C., Raphael, D. R., Randal, M., Stroud, R. M., Gordon, E. M., & Wells, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9367 · Cited by 466
Huc, I., & Lehn, J.-M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2106 · Cited by 460
Pellecchia, M., Sem, D. S., & Wüthrich, K. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd748 · Cited by 420
Boehm, H.-J., Boehringer, M., Bur, D., Gmuender, H., Huber, W., Klaus, W., Kostrewa, D., Kuehne, H., Luebbers, T., Meunier-Keller, N., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000017s · Cited by 375
Characteristic Physical Properties and Structural Fragments of Marketed Oral Drugs
Vieth, M., Siegel, M. G., Higgs, R. E., Watson, I. A., Robertson, D. H., Savin, K. A., Durst, G. L., & Hipskind, P. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030267j · Cited by 359
Highly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase
Pang, Y.-P., Quiram, P., Jelacic, T., Hong, F., & Brimijoin, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23646 · Cited by 344
Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation
Bourne, Y., Kolb, H. C., Radić, Z., Sharpless, K. B., Taylor, P., & Marchot, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308206100 · Cited by 332
Discovering novel ligands for macromolecules using X-ray crystallographic screening
Nienaber, V. L., Richardson, P. L., Klighofer, V., Bouska, J. J., Giranda, V. L., & Greer, J. (2000) · Nature Biotechnology · doi:10.1038/80319 · Cited by 322
Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR
Hajduk, P. J., Sheppard, G., Nettesheim, D. G., Olejniczak, E. T., Shuker, S. B., Meadows, R. P., Steinman, D. H., Carrera, G. M., Marcotte, P. A., Severin, J., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9702778 · Cited by 317
Human β-tryptase is a ring-like tetramer with active sites facing a central pore
Pereira, P. J. B., Bergner, A., Macedo-Ribeiro, S., Huber, R., Matschiner, G., Fritz, H., Sommerhoff, C. P., & Bode, W. (1998) · Nature · doi:10.1038/32703 · Cited by 301
The SHAPES strategy: an NMR-based approach for lead generation in drug discovery
Fejzo, J., Lepre, C. A., Peng, J. W., Bemis, G. W., Ajay, Murcko, M. A., & Moore, J. M. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(00)80022-8 · Cited by 271
Discovery of a Potent Small Molecule IL-2 Inhibitor through Fragment Assembly
Braisted, A. C., Oslob, J. D., Delano, W. L., Hyde, J., McDowell, R. S., Waal, N., Yu, C., Arkin, M. R., & Raimundo, B. C. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034247i · Cited by 256
Szczepankiewicz, B. G., Liu, G., Hajduk, P. J., Abad-Zapatero, C., Pei, Z., Xin, Z., Lubben, T. H., Trevillyan, J. M., Stashko, M. A., Ballaron, S. J., et al. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0296733 · Cited by 231
In situ assembly of enzyme inhibitors using extended tethering
Erlanson, D. A., Lam, J. W., Wiesmann, C., Luong, T. N., Simmons, R. L., DeLano, W. L., Choong, I. C., Burdett, M. T., Flanagan, W. M., Lee, D., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt786 · Cited by 203
Murray, C. W., & Verdonk, M. L. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1022446720849 · Cited by 200
Self-citationMaly, D. J., Choong, I. C., & Ellman, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2419 · Cited by 189
Liu, G., Xin, Z., Pei, Z., Hajduk, P. J., Abad-Zapatero, C., Hutchins, C. W., Zhao, H., Lubben, T. H., Ballaron, S. J., Haasch, D. L., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034122o · Cited by 162
SAR by MS: A Ligand Based Technique for Drug Lead Discovery Against Structured RNA Targets
Swayze, E. E., Jefferson, E. A., Sannes, K. A., Blyn, L. B., Risen, L. M., Arakawa, S., Osgood, S. A., Hofstadler, S. A., & Griffey, R. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255466 · Cited by 145
Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries
Hochgürtel, M., Kroth, H., Piecha, D., Hofmann, M. W., Nicolau, C. S., Krause, S., Schaaf, O., Sonnenmoser, G., & Eliseev, A. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052703799 · Cited by 139
Novel Inhibitors of Erm Methyltransferases from NMR and Parallel Synthesis
Hajduk, P. J., Dinges, J., Schkeryantz, J. M., Janowick, D. A., Kaminski, M., Tufano, M. D., Augeri, D. J., Petros, A. M., Nienaber, V. L., Zhong, P., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990293a · Cited by 119
The genesis of high-throughput structure-based drug discovery using protein crystallography
Kühn, P., Wilson, K. P., Patch, M. G., & Stevens, R. C. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00361-7 · Cited by 111
Hochgürtel, M., Biesinger, R., Kroth, H., Piecha, D., Hofmann, M. W., Krause, S., Schaaf, O., Nicolau, C. S., & Eliseev, A. V. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm025589m · Cited by 106
Rao, J., Lahiri, J., Weis, R. M., & Whitesides, G. M. (2000) · Journal of the American Chemical Society · doi:10.1021/ja992648l · Cited by 102
Lesuisse, D., Lange, G., Deprez, P., Bénard, D., Schoot, B. M., Delettre, G., Marquette, J.-P., Broto, P., Jean‐Baptiste, V., Bichet, P., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010927p · Cited by 90
Liebeschuetz, J. W., Jones, S. D., Morgan, P. J., Murray, C. W., Rimmer, A. D., Roscoe, J. M. E., Waszkowycz, B., Welsh, P. M., Wylie, W. A., Young, S. C., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010944e · Cited by 86
Self-citationWendt, M. D., Rockway, T. W., Geyer, A. G., McClellan, W. J., Weitzberg, M., Zhao, X., Mantei, R. A., Nienaber, V. L., Stewart, K. D., Klinghofer, V., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0300072 · Cited by 65
Design of Adenosine Kinase Inhibitors from the NMR-Based Screening of Fragments
Hajduk, P. J., Gomtsyan, A. R., DiDomenico, S., Cowart, M., Bayburt, E. K., Solomon, L. R., Severin, J. M., Smith, R. A., Walter, K. A., Holzman, T. F., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000373a · Cited by 64
Potent selective nonpeptidic inhibitors of human lung tryptase
Burgess, L. E., Newhouse, B. J., Ibrahim, P. N., Rizzi, J. P., Kashem, M. A., Hartman, A., Brandhuber, B. J., Wright, C. D., Thomson, D. S., Vigers, G. P. A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8348 · Cited by 62
Lange, G., Lesuisse, D., Deprez, P., Schoot, B. M., Loenze, P., Bénard, D., Marquette, J.-P., Broto, P., Sarubbi, E., & Mandine, E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020970s · Cited by 56
van Dongen, M. J. P., Uppenberg, J., Svensson, S., Lundbäck, T., Åkerud, T., Wikström, M., & Schultz, J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja017830c · Cited by 48
Cited by
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Navigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002
Tron, G. C., Pirali, T., Billington, R. A., Canonico, P. L., Sorba, G., & Genazzani, A. A. (2008) · Medicinal Research Reviews · doi:10.1002/med.20107 · Cited by 996
Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00315-3 · Cited by 891
Hybrid Molecules with a Dual Mode of Action: Dream or Reality?
Meunier, B. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000843 · Cited by 929
Metadata
- Authors
- Rees, D. C., Congreve, Murray, C. W., & Carr, R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-08
- Volume
- 3
- Issue
- 8
- Pages
- 660-672
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2028816469
- Cited by
- 798
- References
- 46
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.